Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by Frostyfreshon Feb 02, 2017 1:12pm
169 Views
Post# 25790196

RE:RE:not intrested

RE:RE:not intrested
A market correction will hit mostly companies who are overvalued. That can't really be said about Merus; just look at the book price of the stock. A market correction might even be great for Merus, as people search for undervalued places to put their money and ride out the storm.


Someone also needs to tell Fishman nobody gives a sh*t about his fluffy EBITDA metrics and he needs to focus on EARNINGS.  
<< Previous
Bullboard Posts
Next >>